Search

Your search keyword '"Kelemen, Linda E."' showing total 48 results

Search Constraints

Start Over You searched for: Author "Kelemen, Linda E." Remove constraint Author: "Kelemen, Linda E." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
48 results on '"Kelemen, Linda E."'

Search Results

1. Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

2. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

3. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

4. Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes.

5. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

6. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

7. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

8. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

9. Table S1 from A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

10. Online Supplementary Materials from A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

11. Supplementary Table S3 from Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium

12. Supplementary Methods and Tables from The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers

13. Supplemental Tables S1-S4 from Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium

14. Supplementary Tables 1-2 from Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium

15. Data from Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium

16. Supplementary Figure S1 from Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium

17. Data from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

18. Supplemental Table 1 from History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

19. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

20. Data from History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

21. Supplementary table and figure legends from Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium

22. Supplementary Tables 1-9 from Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

23. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

24. Supplementary Data from Inherited Determinants of Ovarian Cancer Survival

25. Supplementary Tables 1-7 from Common Variation in Nemo-Like Kinase Is Associated with Risk of Ovarian Cancer

26. Supplementary Figure Legend from Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

28. Supplementary Figure Legend 1 from Common Variation in Nemo-Like Kinase Is Associated with Risk of Ovarian Cancer

29. Supplementary Tables 1-7 from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

30. Supplementary Figures 1-4 from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

31. Supplementary Figure 1 from Common Variation in Nemo-Like Kinase Is Associated with Risk of Ovarian Cancer

32. Supplementary Figure 1 from Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

33. Data from Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

36. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

39. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

43. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

45. Adult Day Care in South Carolina: Identification of Need and Opportunity.

46. Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

47. Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

48. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 + TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

Catalog

Books, media, physical & digital resources